Efficacy, safety, and tolerability of nivasorexant in adults with binge eating disorder: A randomized, Phase II proof of concept trial.

Susan L McElroy,Preciosa M Coloma,Benjamin Berger,Anna I Guerdjikova, J Mark Joyce,Michael R Liebowitz,Scott Pain, Cristina Rabasa

The International journal of eating disorders（2023）

引用 0|浏览8

暂无评分

摘要

The results of this Phase II study indicate that nivasorexant was well tolerated in adults with BED, but did not improve binge eating behavior over placebo. Further research is needed to improve our understanding of the role of the orexin-1 receptor in BED.

查看译文

关键词

binge-eating disorder, clinical trial, orexin-1 receptor, Phase 2, proof-of-concept

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要